P 17 (Nuplazid 17 mg)
Generic Name: pimavanserin
Pill imprint P 17 has been identified as Nuplazid 17 mg.
Nuplazid is used in the treatment of parkinson's disease psychosis and belongs to the drug class atypical antipsychotics. Nuplazid 17 mg is classified as a Schedule U controlled substance under the Controlled Substance Act (CSA).
More about Nuplazid (pimavanserin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.